Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-645 in acute migraine
NCT07116499Phase 2Terminated
- Sponsor
- Kallyope
- Start
- Aug 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of K-645 in migraine, sponsored by Kallyope. Started Aug 2025; status: terminated.
02
Drugs
K-645
03
Conditions
migraine
Beyond the preview
Go deeper on NCT07116499.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07116499.